Biotech hub on business blitz

BioFusion in Durham, Bio Congress in NYC, SEBIO in Atlanta get look at research campus resources

September 18, 2006 — DURHAM, NC — Thanks to a barnstorming business tour, the biotech industry is getting a look at the remarkable resources amassing at the $1 billion North Carolina Research Campus ( Next up: BioFusion in Durham on September 18.

Vice President of Business Development Clyde Higgs meets with corporate leaders, venture capitalists, scientists and others at three key life sciences events:

* The Biotechnology and Life Sciences Global Venture Congress, September 14-15, at Madison Square Garden in New York City.

* BioFusion 2006 presented by BioSouth, Monday, September 18, at Durham’s Washington Duke Inn. Higgs will present on the noon panel, “Bioscience Developments and Partnering Opportunities in the Southern United States.”

* The Southeastern BIO Investor Forum, November 8-10, in Atlanta.

Plans for the campus, a public-private partnership, combine the know-how of the private sector with the research power of Duke University, the N.C. Community College System, the University of North Carolina and other higher education institutions.

David H. Murdock (owner and chairman of Dole Food Company and Castle & Cooke Inc.) proposed the project in late 2005 and is providing much of its support. In February, then U.S. Treasury Sec. John Snow visited the campus site, saying, “We’ll continue to lead the global economy because of what you are doing here today.”

For more information, please contact Billy Warden at (919) 882-1968 or (919) 412-0630.


Other features of the research campus ( ) include:

* A 350-acre campus that will strengthen North Carolina’s biotech corridor, including the Research Triangle Park, the Triad, Asheville and Charlotte.

* An initial 311,000-square-foot building to house the core laboratory, a state-of-the-art contract manufacturing biogenic facility and tenants.

* One million square feet of office and laboratory space, 350,000 square feet of new retail and commercial space and approximately 700 new residential units.


BioSouth is dedicated to the advancement of southern bioscience companies and institutions through programs and conferences to support commercialization of products and partnerships within the global biotech, pharmaceutical and medical device communities. By working with our international partners, we are developing alliances, licensing agreements and partnerships with southern life science companies, research institutions and universities. For more information visit:

Billy Warden


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.